Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.
S, K., A, P., S, S., & R, Z. (2026). Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.. Clinical transplantation. https://doi.org/10.1111/ctr.70638
S K, A P, S S, R Z. Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.. Clinical transplantation. 2026; doi: 10.1111/ctr.70638
S K, A P, S S, et al. Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.[J]. Clinical transplantation. 2026. DOI: 10.1111/ctr.70638.
@article{s2026,
author = {Kadir S and Pelaez A and Sasidharan S and Zolty R},
title = {Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.},
journal = {Clinical transplantation},
year = {2026},
doi = {10.1111/ctr.70638},
note = {PMID: 42579331},
}
TY - JOUR AU - Kadir S AU - Pelaez A AU - Sasidharan S AU - Zolty R TI - Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation. T2 - Clinical transplantation PY - 2026 DO - 10.1111/ctr.70638 AN - PMID:42579331 ER -
OBJECTIVES: Pre-transplant echocardiography is routinely performed in kidney transplant candidates, although it remains unclear which parameters are associated with the broad spectrum of post-transplant complications beyond cardiovascular events. Left atrial volume index (LAVI) reflects chronic diastolic burden, and its relationship with overall post-transplant morbidity has not been well defined. MATERIAL AND METHODS: In a single-center retrospective cohort of 242 adults undergoing first kidney-only transplantation (2020 to 2022) with pre-transplant echocardiography within 12 months, the main outcome was a composite of one-year post-transplant complications. Multivariable logistic regression was adjusted for age, sex, BMI, diabetes, and deceased donor status. RESULTS: LAVI was abnormal (>34 mL/m2) in 83 of 218 patients (38.1%), with largely preserved systolic function (mean LVEF 59.1 ± 6.2%). Abnormal LAVI was associated with the composite outcome (69.5% versus 53.2%, adjusted OR 2.01, 95% CI 1.08 to 3.73, p = 0.027), with a graded increase across tertiles (trend p = 0.030). No individual complication category reached significance. Excluding cardiac events, the non-cardiac composite was similar in magnitude but not conventionally significant (adjusted OR 1.80, 95% CI 0.98 to 3.32). No other echocardiographic parameter was associated with the outcomes. Atrial fibrillation analyses were exploratory and should be interpreted cautiously. CONCLUSIONS: Pre-transplant LAVI >34 mL/m2 was associated with a higher burden of one-year post-transplant morbidity, with a graded relationship across severity. No individual complication category reached significance. These findings are hypothesis-generating and require prospective validation before clinical use.